Humacyte Stock

humacyte.comBioTechFounded: 2004Funding to Date: $440MM

Humacyte is the developer of a biotechnology platform designed to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine.

Register for Details

For more details on financing and valuation for Humacyte, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Humacyte.

Register Today
Register for Details

For more details on financing and valuation for Humacyte, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Jeffrey Lawson MD
President & Chief Executive Officer
Carrie Cox
Chairman & Chief Executive Officer
Douglas Blankenship
Chief Financial Officer
Theodore Lithgow Ph.D
Chief Operating Officer
William Tente
Chief Regulatory Officer
Juliana Blum Ph.D
Co-Founder & Vice President, Business Operations & Tissue Services
Laura Niklason MD
Co-Founder & Board Member
Shannon Dahl Ph.D
Co-Founder
Heather Prichard Ph.D
Senior Vice President of Product Development
Jack Harvey
Vice President, Bioprocessing

Board Members

Brady Dougan
Credit Suisse
Carrie Cox
Dale Sander
Kathleen Sebelius
Laura Niklason MD
Max Wallace JD
Robert Anderson MD
Robert Langer Ph.D

Other companies like Humacyte in the BioTech sector

Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.89B